Cuna, Jane A.
HRN: 24-71-72 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/06/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/06/2024
06/13/2024
IV
300mg
Q6h
Valvular Heart Disease
Waiting Final Action
Indication: Empiric Type of Infection: Cardiovascular Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes